CCR2 and angina pectoris: Interestingly, Yang et al. (2015) showed that patients with unstable angina treated with atorvastatin presented decreased CCR2 expression in CD14+ monocytes after percutaneous coronary intervention (PCI) compared to the control group due to the anti-inflammatory activity of the atorvastatin, as suggested by the authors.